Skip to main content
. 2020 Sep 22;11(38):3502–3514. doi: 10.18632/oncotarget.27748

Table 1. Biological response to treatments.

CON-SALINE CON-SS-31 TB-SALINE TB-SS-31
Initial Weight (g) 22.75 ± 0.27 22.48 ± 0.24 22.70 ± 0.22 22.98 ± 0.18
Final Weight (g) 26.01 ± 0.51 24.65 ± 0.62 21.78 ± 1.01* 24.72 ± 0.55
Final Weight (tumor-free) (g) 26.01 ± 0.51 24.65 ± 0.62 19.45 ± 0.94* 22.40 ± 0.44^
Tumor Mass (g) 2.32 ± 0.16 2.32 ± 0.30
Heart Weight (mg) 121.8 ± 3.6 119.3 ± 3.6 94.1 ± 3.9# 106.3 ± 3.5^
Tibialis Anterior (mg) 48.2 ± 1.6 47.6 ± 1.5 36.7 ± 1.0# 38.4 ± 1.0#
Gastrocnemius (mg) 139.4 ± 5.2 138.3 ± 4.0 108.0 ± 10.8# 114.3 ± 6.2
Plantaris (mg) 17.4 ± 1.3 16.4 ± 0.8 12.0 ± 0.9# 13.9 ± 1.3
EDL (mg) 8.8 ± 0.3 8.7 ± 0.7 7.5 ± 0.4 7.6 ± 0.6

Differences in body weight, tumor weight and muscle weight between experimental groups. Values are presented as means ± SEM. *significantly different versus all groups (p < 0.05); ^ significantly different versus CON-SALINE (p < 0.05); #significantly different versus CON-SALINE and CON-SS-31 (p < 0.05).